Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Accel. buyback
Inv. presentation
Quarterly results
CC transcript
|
|
PFIZER INC (PFE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/23/2023 |
SC 13G/A
| PFIZER INC reports a 19% stake in Pyxis Oncology, Inc. |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2023 |
SC 13G/A
| STATE STREET CORP reports a 5.1% stake in AMENDED FILING PFIZER INC |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| STATE STREET CORP reports a 5.1% stake in AMENDED FILING PFIZER INC |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 4.8% stake in SpringWorks Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 2% stake in Cortexyme, Inc. |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 4.5% stake in ContraFect Corporation |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 3.8% stake in ESSA Pharma Inc. |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 3.9% stake in BioAtla, Inc. |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 3.2% stake in Wave Life Sciences Ltd. |
| 02/11/2022 |
SC 13G/A
| PFIZER INC reports a 1.1% stake in 4D Molecular Therapeutics, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.3% stake in Pfizer Inc. |
| 01/31/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/25/2021 |
SC 13G/A
| PFIZER INC reports a 7% stake in Cortexyme, Inc. |
| 02/12/2021 |
SC 13G/A
| PFIZER INC reports a 7.3% stake in Cortexyme, Inc. |
| 02/12/2021 |
SC 13G/A
| PFIZER INC reports a 6.4% stake in ContraFect Corporation |
| 02/12/2021 |
SC 13G/A
| PFIZER INC reports a 9.4% stake in SpringWorks Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| PFIZER INC reports a 4.1% stake in Morphic Holding, Inc. |
| 02/12/2021 |
SC 13G/A
| PFIZER INC reports a 0% stake in Mersana Therapeutics, Inc. |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/29/2021 |
SC 13G/A
| BlackRock Inc. reports a 7.1% stake in PFIZER INC |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 7.7% stake in PFIZER INC |
| 02/13/2019 |
SC 13G/A
| PFIZER INC reports a 4.2% stake in Rhythm Pharmaceuticals, Inc. |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| PFIZER INC reports a 3.9% stake in Protalix BioTherapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| PFIZER INC reports a 9.7% stake in Mersana Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| PFIZER INC reports a 0% stake in CytomX Therapeutics, Inc. |
| 02/13/2018 |
SC 13G/A
| PFIZER INC reports a 1.7% stake in Synlogic, Inc. |
| 02/13/2018 |
SC 13G/A
| PFIZER INC reports a 1.3% stake in Merus N.V. |
| 02/09/2018 |
SC 13G/A
| VANGUARD GROUP INC reports a 7.3% stake in Pfizer Inc |
|
|
|